07:00 , Mar 24, 2014 |  BC Week In Review  |  Financial News

Saniona completes IPO

Saniona AB (AktieTorget: SANION), Ballerup, Denmark   Business: Neurology   Date completed: 3/20/14   Type: IPO   Raised: SEK17 million ($2.7 million)   Shares: 3.4 million   Price: SEK5   Shares after offering: 13.9 million...
07:00 , Mar 24, 2014 |  BioCentury  |  Finance

Quick turn

Quick turn In less than a year, Atlas has set up a potential exit for Ataxion Inc. via a $17 million tranched series A round that will fund the company through completion of a Phase...
23:58 , Mar 20, 2014 |  BC Extra  |  Financial News

Saniona raises $2.7 million in Swedish IPO

Saniona AB (AktieTorget:SANION) raised SEK17 million ($2.7 million) in an IPO in Sweden through the sale of 3.4 million shares at SEK5. The price values the company at SEK69.4 million ($10.8 million). Saniona (formerly Aniona...
07:00 , Oct 24, 2013 |  BC Innovations  |  Strategy

Synaptic synopsis

The early promise that neurotransmitter research would unlock the door for neurological diseases has devolved into sagging interest from several pharmas following repeated failures in clinical trials. Now, genetic findings are pointing to new targets...
07:00 , Sep 10, 2012 |  BC Week In Review  |  Company News

Aniona, NeuroSearch, J&J deal

NeuroSearch transferred to Aniona rights and obligations under a 2009 deal with Johnson & Johnson's Janssen Pharmaceutica N.V. subsidiary to discover and develop therapies for CNS diseases. The R&D deal expires August 2013. Last year,...
08:00 , Dec 19, 2011 |  BC Week In Review  |  Company News

NeuroSearch cardiovascular news

NeuroSearch will spin out newco Acesion Pharma ApS to focus on developing products to treat atrial fibrillation (AF) based on NeuroSearch's sodium and potassium ion channels program. Acesion will receive an option to license new...